MedPath
NMPA Approval

Adalimumab Solution for Injection

S20170019

ABBVIE LTD

August 14, 2019

S20170019

Drug Information

阿达木单抗注射液

修美乐

修美乐

注射剂

40mg/0.8ml

生物制品

August 14, 2019

August 13, 2024

Company Information

Applicant Company

ABBVIE LTD

Maidenhead,SL6 4UB,United Kingdom

Manufacturing Company

vetter pharma-fertigung gmbh & co.kg

Schützenstrasse 87 and 99-101,88212 Ravensburg, Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

阿达木单抗注射液 - NMPA 批准文号 | MedPath